Wellington Management Group
SVA

Wellington Management Group’s Sinovac Biotech, Ltd SVA Stock Holding History

Wellington Management Group’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-69,098
Closed -$544K – 2441
2017
Q4 		$544K Hold
69,098
– – ﹤0.01% 2026
2017
Q3 		$486K Buy
69,098
+58,848
+574% +$402K ﹤0.01% 2046
2017
Q2 		$69K Hold
10,250
– – ﹤0.01% 2185
2017
Q1 		$59K Sell
10,250
-5,511,012
-100% -$31.9M ﹤0.01% 2228
2016
Q4 		$32.6M Buy
5,521,262
+146,603
+3% +$882K 0.01% 848
2016
Q3 		$31.7M Buy
5,374,659
+134,447
+3% +$791K 0.01% 829
2016
Q2 		$31.1M Sell
5,240,212
-12,023
-0.2% -$73.7K 0.01% 807
2016
Q1 		$33.6M Buy
5,252,235
+22,814
+0.4% +$137K 0.01% 779
2015
Q4 		$29.9M Buy
5,229,421
+646,394
+14% +$3.48M 0.01% 833
2015
Q3 		$23.3M Buy
4,583,027
+514,621
+13% +$2.73M 0.01% 918
2015
Q2 		$21.4M Sell
4,068,406
-502,106
-11% -$2.65M 0.01% 997
2015
Q1 		$22.7M Buy
4,570,512
+181,452
+4% +$894K 0.01% 1000
2014
Q4 		$23M Buy
4,389,060
+130,311
+3% +$664K 0.01% 999
2014
Q3 		$20.5M Buy
4,258,749
+313,284
+8% +$1.68M 0.01% 1003
2014
Q2 		$22.3M Sell
3,945,465
-1,175,478
-23% -$7.14M 0.01% 1003
2014
Q1 		$36.9M Buy
5,120,943
+1,232,470
+32% +$8.16M 0.01% 838
2013
Q4 		$23.8M Buy
3,888,473
+986,740
+34% +$5.95M 0.01% 947
2013
Q3 		$17.4M Buy
2,901,733
+107,662
+4% +$515K 0.01% 1055
2013
Q2 		$11M Buy
+2,794,071
New +$10.4M ﹤0.01% 1149

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wellington Management Group's SVA Position: Q1 2018 in Review

Wellington Management Group sold out of Sinovac Biotech, Ltd (SVA) in Q1 2018, closing a stake of 69,098 shares — an estimated $544K sold.

Wellington Management Group first reported a position in SVA in Q2 2013 and held it in 19 quarters. The position peaked at $36.9M in Q1 2014. 29 funds tracked by Wall St. Rank hold SVA as of Q1 2018.

  • Wellington Management Group reported no remaining Sinovac Biotech, Ltd position as of Q1 2018 after selling out during the quarter.
  • Wellington Management Group sold 69,098 Sinovac Biotech, Ltd shares in Q1 2018, an estimated $544K.
  • Wellington Management Group first reported a position in Sinovac Biotech, Ltd in Q2 2013 and held it in 19 quarters.
  • Wellington Management Group's Sinovac Biotech, Ltd position peaked at $36.9M in Q1 2014.
  • 29 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2018.

Based on Wellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.